HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Minematsu, N. Articles by Ishizaka, A. Search for Related Content PubMed PubMed Citation Articles by Minematsu, N. Articles by Ishizaka, A.

Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms

¹ Division of Pulmonary Medicine, Dept of Medicine, Keio University, Tokyo, and ² Dept of Medicine, Tokyo Electric Power Company Hospital, Tokyo, Japan.

CORRESPONDENCE: H. Nakamura, Dept of Medicine, Tokyo Electric Power Company Hospital, 9-2 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan. Fax: 81 343566419. E-mail: hnakamura{at}cpnet.med.keio.ac.jp

Keywords: CYP2A6, genetic polymorphism, nicotine, smoking habit

Received: May 12, 2005
Accepted October 24, 2005

The whole gene deletion CYP2A6*4, the defect of the main nicotine oxidase, contributes to limiting lifelong and daily cigarette consumption. However, the effects on smoking habits of CYP2A6*7 and *9, two major functional polymorphisms common in Asian populations, have not been reported.

The present study examined the relationship between polymorphisms *4, *7 and *9 with the smoking habits of 200 Japanese smokers who visited the Keio University Hospital (Tokyo, Japan).

The allele frequencies of *1 (wild type), *4, *7 and *9 were 52, 17, 11 and 20%, respectively. When the three polymorphisms were considered simultaneously, the percentages of homozygous wild type, heterozygote, and homozygous mutants and compound heterozygotes were 26.0, 52.5 and 21.5%, respectively. Homozygous mutants and compound heterozygotes (n = 43) smoked fewer cigarettes daily than heterozygotes (n = 105) and homozygous wild-type individuals (n = 52). Smokers with *7/*7, *9/*9 or *7/*9 had lower daily cigarette consumption than smokers with *1/*1.

In conclusion, polymorphisms *4, *7 and *9 of CYP2A6 were detected in approximately three out of four Japanese smokers, and their daily cigarette consumption was genetically modulated by these functional polymorphisms.

This article has been cited by other articles:

				M. I. Damaj, E. C. K. Siu, E. M. Sellers, R. F. Tyndale, and B. R. Martin Inhibition of Nicotine Metabolism by Methoxysalen: Pharmacokinetic and Pharmacological Studies in Mice J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 250 - 257. [Abstract] [Full Text] [PDF]